Loading clinical trials...
Loading clinical trials...
Predictors of Severe COVID-19 Outcomes (PRESCO)
Conditions
Locations
8
United States
The University of Arizona
Tucson, Arizona, United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
University of Illinois at Chicago
Chicago, Illinois, United States
Rush University Medical Center
Chicago, Illinois, United States
Weill Cornell Medical College
New York, New York, United States
University of Texas Southwestern Medical Center
Dallas, Texas, United States
Start Date
May 28, 2020
Primary Completion Date
September 23, 2021
Completion Date
September 23, 2021
Last Updated
May 28, 2024
NCT06631287
NCT05101213
NCT04565665
NCT06871293
NCT07504731
NCT06703073
Lead Sponsor
Verily Life Sciences LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions